PNC FINANCIAL SERVICES GROUP, INC. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$42,974
-30.1%
10,2320.0%0.00%
Q4 2022$61,494
+6.0%
10,232
+2.3%
0.00%
Q3 2022$58,000
-3.3%
10,000
-1.0%
0.00%
Q2 2022$60,000
+27.7%
10,100
+1.0%
0.00%
Q1 2022$47,000
+88.0%
10,0000.0%0.00%
Q4 2021$25,000
+1150.0%
10,000
+900.0%
0.00%
Q4 2019$2,0001,0000.0%0.00%
Q3 2019$01,0000.0%0.00%
Q2 2019$01,0000.0%0.00%
Q1 2019$01,0000.0%0.00%
Q4 2018$0
-100.0%
1,0000.0%0.00%
Q3 2018$2,0001,0000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders